Oakleaf Care (Hartwell) Limited has been acquired by CareTech Holdings Plc
The private shareholders of Oakleaf Care (Hartwell) Limited (Oakleaf) have sold the company to CareTech Holdings Plc (CareTech) for an undisclosed consideration.
Oakleaf Care provides brain injury rehabilitation to adult males requiring specialist care and long-term support. Based in Northamptonshire, UK, the group operates over 80 beds across a number of sites, with highly trained staff providing a seamless rehabilitation pathway of care for men with acquired brain injury (ABI). The business continues to expand, with a new 22-bed care home opening this quarter bringing the total to over 100 beds.
CareTech is a provider of specialist social care services in the UK, supporting adults and children with a wide range of complex needs across more than 250 specialist services. This acquisition gives CareTech a presence in ABI rehabilitation, enabling it to offer additional pathways to its client care group.
Oaklins Smith & Williamson, based in the UK, advised the seller in this transaction.
Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Learn morePhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Learn moreMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Learn more